Regulatory14 Apr 2026, 04:19 pm
Vivanza Biosciences Confirms Non-Applicability of Deviation Statement
AI Summary
Vivanza Biosciences Ltd has confirmed the non-applicability of the Statement of Deviation or Variation from proceeds of public/rights/preferential issues, as per Regulation 32 of SEBI (LODR) Regulations, 2015, read with SEBI Circular dated December 24, 2019. The company stated that it has not raised any further funds through Public Issue, Rights Issue, or Preferential Issue, etc., making the submission of such a statement unnecessary.
Key Highlights
- Vivanza Biosciences confirms non-applicability of deviation statement.
- Company has not raised funds via public, rights, or preferential issues.
- Compliance with SEBI (LODR) Regulation 32 is noted.
- No funds were raised, hence no deviation statement is required.
- The filing ensures regulatory transparency regarding fund utilization.
Price Impact
More from VIVANZA